Navigation Links
Low brain protein levels associated with neurodegeneration
Date:7/3/2014

Persons with reduced levels of the TREM2 protein could be at greater risk of developing neurodegenerative diseases such as Alzheimer's disease or frontotemporal dementia, according to an international study which included the participation of the Universitat Autnoma de Barcelona and the Sant Pau Biomedical Research Institute (IIB Sant Pau).

The study, published in Science Translational Medicine, reveals the molecular mechanism by which the mutated forms of this protein prevent the amyloid waste cleaning process from functioning correctly and detects a lower level of the functional form of this protein in the cerebrospinal fluid of people suffering from Alzheimer's disease and frontotemporal dementia.

The TREM2 gene is expressed mainly in the microglia, brain cells in charge of phagocytosis and of eliminating cell waste which accumulates in this organ, such as amyloid fibres and other protein aggregates. For some years now it has been known that mutations in TREM2 cause rare and aggressive neurodegenerative diseases known as Nasu-Hakola and FTD-like syndrome. Nevertheless, recent genetic studies have linked other less aggressive mutations in this gene to a higher risk of suffering from other more common neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.

In this study, led by Professor Christian Haass and DR Gernot Kleinberger from the Ludwig Maximilian University of Munich, the role played by TREM2 in the microglia when regulating its function as a phagocyte was revealed.

The study was conducted in two phases. In the first, carried out with microglial cell cultures, scientists observed that when mutated forms of TREM2 are expressed, the protein does not reach the cell membrane and the cells lose their ability to clean the residues accumulated in the brain.

In the second phase, researchers observed in the analyses carried out that patients with Alzheimer's disease or frontotemporal dementia tended to have low levels of TREM2 in their cerebrospinal fluid, while patients with FTD-like syndrome completely lacked this protein.

"Although we must still continue researching, these results suggest that the TREM2 protein plays a fundamental role in the elimination of amyloids and other protein aggregates and its malfunctioning can accelerate neurodegenerative processes. It could also be a useful indicator of neurodegenerative diseases", explains Marc Surez-Calvet, pre-doctoral researcher at the UAB and participant in the study.

The stimulation of TREM2 functions could be a useful strategy when fighting neurodegenerative diseases, the study indicates. "It would be good to continue with the research and observe if acting on the TREM2 to restore or increase its activity could be effective in treating different neurodegenerative pathologies", concludes Albert Lle, IBB researcher and lecturer at the UAB Department of Medicine.


'/>"/>

Contact: Maria Jesus Delgado
MariaJesus.Delgado@uab.cat
34-935-814-049
Universitat Autonoma de Barcelona
Source:Eurekalert

Related biology news :

1. REST is crucial for the timing of brain development
2. Holding a mirror to brain changes in autism
3. Strong scientific evidence that eating berries benefits the brain
4. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
5. Step forward in research into new treatments for brain edema
6. University of Alberta led research may have discovered how memories are encoded in our brains
7. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
8. Friendly to a fault, yet tense: Personality traits traced in brain
9. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
10. Autism risk gene linked to differences in brain structure
11. Amyloid beta in the brain of individuals with Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... 15, 2016 Research and Markets has announced ... 2021" report to their offering. ... ... by 2021 from USD 6.21 Billion in 2016, growing at a ... of the bioinformatics market is driven by the growing demand for ...
(Date:6/27/2016)... 2016 Research and Markets has announced the ... report to their offering. The ... to grow at a CAGR of 12.28% during the period ... an in-depth market analysis with inputs from industry experts. The report ... years. The report also includes a discussion of the key vendors ...
(Date:6/22/2016)... , June 22, 2016 On Monday, the ... to industry to share solutions for the Biometric Exit ... Customs and Border Protection (CBP), explains that CBP intends ... departing the United States , in ... to defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... CA (PRWEB) , ... November 30, 2016 , ... ... a new moving magnet Voice Coil Actuator with a flexure design that ensures ... long life with cost-effective pricing and is ideally suited where extreme precision is ...
(Date:11/30/2016)... 2016  The Allen Institute for Cell Science ... publicly available collection of gene edited, fluorescently tagged ... cellular structures with unprecedented clarity. Distributed through the ... are a crucial first step toward visualizing the ... makes human cells healthy and what goes wrong ...
(Date:11/30/2016)... 2016 Part of 5m$ Investment in ... ... Aptuit, LLC today announced that it had successfully completed the ... compounds have increased the Screening Collection to over 400,000. The ... capabilities of the company. This expansion, complemented by new robotics ...
(Date:11/30/2016)... ... November 30, 2016 , ... On 28 November 2016, the International Union of ... nihonium (Nh), moscovium (Mc), tennessine (Ts), and oganesson (Og), respectively for element 113, 115, ... proposed by the discoverers have been approved by the IUPAC Bureau. The IUPAC Council ...
Breaking Biology Technology: